Anti-DPH1 monoclonal antibody

Pre-made anti-DPH1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DPH1/DPH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2462-Ab-1/ GM-Tg-hg-IP2462-Ab-2Anti-Human DPH1 monoclonal antibodyHuman
GM-Tg-rg-IP2462-Ab-1/ GM-Tg-rg-IP2462-Ab-2Anti-Rat DPH1 monoclonal antibodyRat
GM-Tg-mg-IP2462-Ab-1/ GM-Tg-mg-IP2462-Ab-2Anti-Mouse DPH1 monoclonal antibodyMouse
GM-Tg-cynog-IP2462-Ab-1/ GM-Tg-cynog-IP2462-Ab-2Anti-Cynomolgus/ Rhesus macaque DPH1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2462-Ab-1/ GM-Tg-felg-IP2462-Ab-2Anti-Feline DPH1 monoclonal antibodyFeline
GM-Tg-cang-IP2462-Ab-1/ GM-Tg-cang-IP2462-Ab-2Anti-Canine DPH1 monoclonal antibodyCanine
GM-Tg-bovg-IP2462-Ab-1/ GM-Tg-bovg-IP2462-Ab-2Anti-Bovine DPH1 monoclonal antibodyBovine
GM-Tg-equg-IP2462-Ab-1/ GM-Tg-equg-IP2462-Ab-2Anti-Equine DPH1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2462-Ab-1/ GM-Tg-hg-IP2462-Ab-2; GM-Tg-rg-IP2462-Ab-1/ GM-Tg-rg-IP2462-Ab-2;
GM-Tg-mg-IP2462-Ab-1/ GM-Tg-mg-IP2462-Ab-2; GM-Tg-cynog-IP2462-Ab-1/ GM-Tg-cynog-IP2462-Ab-2;
GM-Tg-felg-IP2462-Ab-1/ GM-Tg-felg-IP2462-Ab-2; GM-Tg-cang-IP2462-Ab-1/ GM-Tg-cang-IP2462-Ab-2;
GM-Tg-bovg-IP2462-Ab-1/ GM-Tg-bovg-IP2462-Ab-2; GM-Tg-equg-IP2462-Ab-1/ GM-Tg-equg-IP2462-Ab-2
Products NameAnti-DPH1 monoclonal antibody
Formatmab
Target NameDPH1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DPH1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2462-Ag-1Recombinant multi-species DPH1/ DEDSSH/ DPH2L protein
    ORF Viral VectorpGMLPm001820mouse Dph1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001820mouse Dph1 Lentivirus particle


    Target information

    Target IDGM-IP2462
    Target NameDPH1
    Gene ID1801,116905,287523,721275,480653,101083810,534099,100060117
    Gene Symbol and Synonyms2310011M22Rik,4930488F09Rik,DEDSSH,DPH1,DPH1-OVCA2,DPH2L,DPH2L1,OVCA1,RGD1562694
    Uniprot AccessionQ9BZG8,Q3SYT1
    Uniprot Entry NameDPH1_HUMAN,DPH1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000108963
    Target ClassificationN/A

    The target: DPH1, gene name: DPH1, also named as DEDSSH, DPH2L, DPH2L1, OVCA1. The protein encoded by this gene is an enzyme involved in the biosynthesis of diphthamide, a modified histidine found only in elongation factor-2 (EEF2). Diphthamide residues in EEF2 are targeted for ADP-ribosylation by diphtheria toxin and Pseudomonas exotoxin A. Defects in this gene have been associated with both ovarian cancer and autosomal recessive intellectual disability with short stature, craniofacial, and ectodermal anomalies. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.